129 related articles for article (PubMed ID: 25448581)
1. Stability studies of As4S4 nanosuspension prepared by wet milling in Poloxamer 407.
Bujňáková Z; Dutková E; Baláž M; Turianicová E; Baláž P
Int J Pharm; 2015 Jan; 478(1):187-192. PubMed ID: 25448581
[TBL] [Abstract][Full Text] [Related]
2. Preparation, properties and anticancer effects of mixed As
Bujňáková Z; Baláž M; Zdurienčíková M; Sedlák J; Čaplovičová M; Čaplovič Ľ; Dutková E; Zorkovská A; Turianicová E; Baláž P; Shpotyuk O; Andrejko S
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():541-551. PubMed ID: 27987742
[TBL] [Abstract][Full Text] [Related]
3. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology.
George M; Ghosh I
Eur J Pharm Sci; 2013 Jan; 48(1-2):142-52. PubMed ID: 23085547
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
[TBL] [Abstract][Full Text] [Related]
5. Nanosuspension formulations of poorly water-soluble compounds for intravenous administration in exploratory toxicity studies: in vitro and in vivo evaluation.
Fujimura H; Komasaka T; Tomari T; Kitano Y; Takekawa K
J Appl Toxicol; 2016 Oct; 36(10):1259-67. PubMed ID: 26849104
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
Ali HS; York P; Ali AM; Blagden N
J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
[TBL] [Abstract][Full Text] [Related]
7. Glabridin nanosuspension for enhanced skin penetration: formulation optimization, in vitro and in vivo evaluation.
Wang WP; Hul J; Sui H; Zhao YS; Feng J; Liu C
Pharmazie; 2016 May; 71(5):252-7. PubMed ID: 27348968
[TBL] [Abstract][Full Text] [Related]
8. Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - Development of particle design method.
Niwa T; Miura S; Danjo K
Int J Pharm; 2011 Feb; 405(1-2):218-27. PubMed ID: 21167922
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.
Zuo W; Qu W; Li N; Yu R; Hou Y; Liu Y; Gou G; Yang J
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1513-1522. PubMed ID: 28906144
[TBL] [Abstract][Full Text] [Related]
10. Preparation of As
Bujňáková Z; Kello M; Kováč J; Tóthová E; Shpotyuk O; Baláž P; Mojžiš J; Andrejko S
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110683. PubMed ID: 32204110
[TBL] [Abstract][Full Text] [Related]
11. Diclofenac acid nanocrystals as an effective strategy to reduce in vivo skin inflammation by improving dermal drug bioavailability.
Pireddu R; Caddeo C; Valenti D; Marongiu F; Scano A; Ennas G; Lai F; Fadda AM; Sinico C
Colloids Surf B Biointerfaces; 2016 Jul; 143():64-70. PubMed ID: 26998867
[TBL] [Abstract][Full Text] [Related]
12. Arsenic(II) sulfide quantum dots prepared by a wet process from its bulk.
Wang J; Lin M; Zhang T; Yan Y; Ho PC; Xu QH; Loh KP
J Am Chem Soc; 2008 Sep; 130(35):11596-7. PubMed ID: 18693730
[TBL] [Abstract][Full Text] [Related]
13. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
14. Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals.
Martena V; Shegokar R; Di Martino P; Müller RH
Drug Dev Ind Pharm; 2014 Sep; 40(9):1199-205. PubMed ID: 23815299
[TBL] [Abstract][Full Text] [Related]
15. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
[TBL] [Abstract][Full Text] [Related]
16. [Preparation of nanosuspension of quercetin with a miniaturized milling method].
Liu X; Liu J; Pang JY; Shen BD; Shen CY; Lian WQ; Li XF; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2984-2988. PubMed ID: 29139267
[TBL] [Abstract][Full Text] [Related]
17. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
18. Process parameter dependent growth phenomena of naproxen nanosuspension manufactured by wet media milling.
Bitterlich A; Laabs C; Krautstrunk I; Dengler M; Juhnke M; Grandeury A; Bunjes H; Kwade A
Eur J Pharm Biopharm; 2015 May; 92():171-9. PubMed ID: 25766272
[TBL] [Abstract][Full Text] [Related]
19. The Scalability of Wet Ball Milling for The Production of Nanosuspensions.
Lestari MLAD; Müller RH; Möschwitzer JP
Pharm Nanotechnol; 2019; 7(2):147-161. PubMed ID: 30931866
[TBL] [Abstract][Full Text] [Related]
20. Dual centrifugation - A new technique for nanomilling of poorly soluble drugs and formulation screening by an DoE-approach.
Hagedorn M; Bögershausen A; Rischer M; Schubert R; Massing U
Int J Pharm; 2017 Sep; 530(1-2):79-88. PubMed ID: 28733242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
